Cargando…

Fear of cancer recurrence in peritoneal malignancy patients following complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): an observational study protocol

INTRODUCTION: Fear of cancer recurrence (FCR) is correlated with higher depression levels, worse quality of life and increased utilisation of healthcare services. There is no research on FCR in peritoneal malignancy (PM) patients—a rare type of abdominal cancer. This study aims to explore the preval...

Descripción completa

Detalles Bibliográficos
Autores principales: Taher, Rayan, Stanford, Sophia, Carr, Norman, Vanderpuye, Nancy, Chandrakumaran, Kandiah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845210/
https://www.ncbi.nlm.nih.gov/pubmed/35165114
http://dx.doi.org/10.1136/bmjopen-2021-057294
_version_ 1784651623117619200
author Taher, Rayan
Stanford, Sophia
Carr, Norman
Vanderpuye, Nancy
Chandrakumaran, Kandiah
author_facet Taher, Rayan
Stanford, Sophia
Carr, Norman
Vanderpuye, Nancy
Chandrakumaran, Kandiah
author_sort Taher, Rayan
collection PubMed
description INTRODUCTION: Fear of cancer recurrence (FCR) is correlated with higher depression levels, worse quality of life and increased utilisation of healthcare services. There is no research on FCR in peritoneal malignancy (PM) patients—a rare type of abdominal cancer. This study aims to explore the prevalence, trajectory, demographic and clinical characteristics that are associated with FCR and its relationship with quality of life in PM patients. METHODS AND ANALYSIS: This is a cross-sectional study. Validated measures will be used to collect data on the levels of FCR (Fear of Cancer Recurrence Inventory-Short Form) and quality of life (36-Item Short-Form Health Survey) of PM patients who have had surgery in the last 5 years at the Peritoneal Malignancy Institute in Basingstoke Hospital (minimum N=260). Descriptive statistics, Pearson χ(2) tests and correlational tests will be used to analyse the data. ETHICS AND DISSEMINATION: Ethical approval was obtained from the HRA and Health and Care Research Wales (HCRW). The results of this study will be shared with the participants of this study, presented at conferences and PM patients’ days in the form of presentations or posters, and published in a scientific journal. DISCUSSION: The results of this exploratory study will be used to inform a multicentre observational study to explore the effect of FCR on PM patients’ mental health (depression and anxiety), quality of life and healthcare utilisation which will inform a multicentre randomised controlled trial to assess the effectiveness of using evidenced-based interventions to lower FCR in PM patients.
format Online
Article
Text
id pubmed-8845210
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-88452102022-03-01 Fear of cancer recurrence in peritoneal malignancy patients following complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): an observational study protocol Taher, Rayan Stanford, Sophia Carr, Norman Vanderpuye, Nancy Chandrakumaran, Kandiah BMJ Open Oncology INTRODUCTION: Fear of cancer recurrence (FCR) is correlated with higher depression levels, worse quality of life and increased utilisation of healthcare services. There is no research on FCR in peritoneal malignancy (PM) patients—a rare type of abdominal cancer. This study aims to explore the prevalence, trajectory, demographic and clinical characteristics that are associated with FCR and its relationship with quality of life in PM patients. METHODS AND ANALYSIS: This is a cross-sectional study. Validated measures will be used to collect data on the levels of FCR (Fear of Cancer Recurrence Inventory-Short Form) and quality of life (36-Item Short-Form Health Survey) of PM patients who have had surgery in the last 5 years at the Peritoneal Malignancy Institute in Basingstoke Hospital (minimum N=260). Descriptive statistics, Pearson χ(2) tests and correlational tests will be used to analyse the data. ETHICS AND DISSEMINATION: Ethical approval was obtained from the HRA and Health and Care Research Wales (HCRW). The results of this study will be shared with the participants of this study, presented at conferences and PM patients’ days in the form of presentations or posters, and published in a scientific journal. DISCUSSION: The results of this exploratory study will be used to inform a multicentre observational study to explore the effect of FCR on PM patients’ mental health (depression and anxiety), quality of life and healthcare utilisation which will inform a multicentre randomised controlled trial to assess the effectiveness of using evidenced-based interventions to lower FCR in PM patients. BMJ Publishing Group 2022-02-11 /pmc/articles/PMC8845210/ /pubmed/35165114 http://dx.doi.org/10.1136/bmjopen-2021-057294 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Oncology
Taher, Rayan
Stanford, Sophia
Carr, Norman
Vanderpuye, Nancy
Chandrakumaran, Kandiah
Fear of cancer recurrence in peritoneal malignancy patients following complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): an observational study protocol
title Fear of cancer recurrence in peritoneal malignancy patients following complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): an observational study protocol
title_full Fear of cancer recurrence in peritoneal malignancy patients following complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): an observational study protocol
title_fullStr Fear of cancer recurrence in peritoneal malignancy patients following complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): an observational study protocol
title_full_unstemmed Fear of cancer recurrence in peritoneal malignancy patients following complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): an observational study protocol
title_short Fear of cancer recurrence in peritoneal malignancy patients following complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): an observational study protocol
title_sort fear of cancer recurrence in peritoneal malignancy patients following complete cytoreductive surgery (ccrs) and hyperthermic intraperitoneal chemotherapy (hipec): an observational study protocol
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845210/
https://www.ncbi.nlm.nih.gov/pubmed/35165114
http://dx.doi.org/10.1136/bmjopen-2021-057294
work_keys_str_mv AT taherrayan fearofcancerrecurrenceinperitonealmalignancypatientsfollowingcompletecytoreductivesurgeryccrsandhyperthermicintraperitonealchemotherapyhipecanobservationalstudyprotocol
AT stanfordsophia fearofcancerrecurrenceinperitonealmalignancypatientsfollowingcompletecytoreductivesurgeryccrsandhyperthermicintraperitonealchemotherapyhipecanobservationalstudyprotocol
AT carrnorman fearofcancerrecurrenceinperitonealmalignancypatientsfollowingcompletecytoreductivesurgeryccrsandhyperthermicintraperitonealchemotherapyhipecanobservationalstudyprotocol
AT vanderpuyenancy fearofcancerrecurrenceinperitonealmalignancypatientsfollowingcompletecytoreductivesurgeryccrsandhyperthermicintraperitonealchemotherapyhipecanobservationalstudyprotocol
AT chandrakumarankandiah fearofcancerrecurrenceinperitonealmalignancypatientsfollowingcompletecytoreductivesurgeryccrsandhyperthermicintraperitonealchemotherapyhipecanobservationalstudyprotocol